These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 6188989

  • 1. [Immunotherapy of brain tumors].
    Takakura K, Watanabe T.
    No Shinkei Geka; 1982 Dec; 10(12):1245-54. PubMed ID: 6188989
    [No Abstract] [Full Text] [Related]

  • 2. Hybridoma monoclonal antibody treatment of T-cell lymphomas: clinical experience and nursing management.
    DiJulio JE, Bedigian JS.
    Oncol Nurs Forum; 1983 Dec; 10(2):22-27. PubMed ID: 6346276
    [No Abstract] [Full Text] [Related]

  • 3. New therapeutic approaches to treatment of malignant gliomas: chemotherapy and immunotherapy.
    Mahaley MS, Gillespie GY.
    Clin Neurosurg; 1983 Dec; 31():456-69. PubMed ID: 6680086
    [No Abstract] [Full Text] [Related]

  • 4. Immune modulating therapy in gastrointestinal cancer.
    Chachoua A, Green M, Muggia FM.
    Am J Gastroenterol; 1986 Aug; 81(8):623-8. PubMed ID: 2426941
    [No Abstract] [Full Text] [Related]

  • 5. Interferon treatment of human neoplasia.
    Strander H.
    Adv Cancer Res; 1986 Aug; 46():1-265. PubMed ID: 2425561
    [No Abstract] [Full Text] [Related]

  • 6. Immunobiology of human gliomas.
    Bullard DE, Gillespie GY, Mahaley MS, Bigner DD.
    Semin Oncol; 1986 Mar; 13(1):94-109. PubMed ID: 2420011
    [No Abstract] [Full Text] [Related]

  • 7. [Chemotherapy and immunotherapy of intracranial malignant gliomas].
    Knerich R, Adinolfi D, Silvani V, Robustelli della Cuna G, Spanu G, Preti P, Rodriguez y Baena R.
    Minerva Med; 1984 May 19; 75(21):1333-40. PubMed ID: 6203058
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunotherapy of gliomas: a review.
    Ommaya AK.
    Adv Neurol; 1976 May 19; 15():337-59. PubMed ID: 779424
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunotherapy of superficial bladder cancer.
    Shapiro A, Kadmon D, Catalona WJ, Ratliff TL.
    J Urol; 1982 Nov 19; 128(5):891-4. PubMed ID: 6184490
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Use of electric-field-mediated cell fusion to produce hybridomas secreting monoclonal antibodies.
    Zhao X.
    Methods Mol Biol; 1995 Nov 19; 45():61-7. PubMed ID: 7550693
    [No Abstract] [Full Text] [Related]

  • 18. Age-dependent differences in the efficacy of cancer immunotherapy in C57BL and AKR mouse strains.
    Kaptzan T, Skutelsky E, Itzhaki O, Sinai J, Michowitz M, Yossipov Y, Schiby G, Leibovici J.
    Exp Gerontol; 2004 Jul 19; 39(7):1035-48. PubMed ID: 15236763
    [Abstract] [Full Text] [Related]

  • 19. [Value of immunologic studies in malignant tumors of the human brain].
    Romodanov AP, Lisianyĭ NI, Prikhodchenko IA.
    Zh Vopr Neirokhir Im N N Burdenko; 1983 Jul 19; (3):56-9. PubMed ID: 6310917
    [No Abstract] [Full Text] [Related]

  • 20. Cellular immunity in the treatment of brain tumors.
    Wheeler CJ, Yu JS, Black KL.
    Clin Neurosurg; 2004 Jul 19; 51():132-9. PubMed ID: 15571138
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.